Ledger.Open graph →

SEC Form D · filed January 29, 2021

Cancer Prevention Pharmaceuticals, Inc

Offering

$3.0M

Sold

$400K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

TUCSON, AZ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Eugene Gerner, Ph.D · Tucson, AZDirector Jeffrey Jacob · Tucson, AZExec · Director Daniel Donovan · Tucson, AZDirector Andrew Levitch · New York, NYExec Richard Love · SCOTTSDALE, AZDirector John Saxe · TUCSON, AZDirector Richard Love · Scottsdale, AZDirector John Saxe · TUCSON, AZDirector Eugene Gerner, Ph.D · Tucson, AZDirector Jeffrey Jacob · Tucson, AZExec · Director Daniel Donovan · Tucson, AZDirector Andrew Levitch · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗